PortfoliosLab logo
PRCT vs. AI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PRCT and AI is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

PRCT vs. AI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PROCEPT BioRobotics Corporation (PRCT) and C3.ai, Inc. (AI). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PRCT:

-0.25

AI:

-0.19

Sortino Ratio

PRCT:

0.31

AI:

0.33

Omega Ratio

PRCT:

1.03

AI:

1.04

Calmar Ratio

PRCT:

-0.17

AI:

-0.07

Martin Ratio

PRCT:

-0.35

AI:

-0.22

Ulcer Index

PRCT:

24.18%

AI:

28.51%

Daily Std Dev

PRCT:

65.16%

AI:

63.11%

Max Drawdown

PRCT:

-63.51%

AI:

-94.22%

Current Drawdown

PRCT:

-41.57%

AI:

-86.81%

Fundamentals

Market Cap

PRCT:

$3.03B

AI:

$3.17B

EPS

PRCT:

-$1.69

AI:

-$2.23

PS Ratio

PRCT:

12.16

AI:

8.64

PB Ratio

PRCT:

7.79

AI:

3.69

Total Revenue (TTM)

PRCT:

$249.12M

AI:

$280.33M

Gross Profit (TTM)

PRCT:

$154.96M

AI:

$168.35M

EBITDA (TTM)

PRCT:

-$80.65M

AI:

-$226.24M

Returns By Period

In the year-to-date period, PRCT achieves a -27.83% return, which is significantly higher than AI's -32.01% return.


PRCT

YTD

-27.83%

1M

9.81%

6M

-32.36%

1Y

-16.01%

5Y*

N/A

10Y*

N/A

AI

YTD

-32.01%

1M

17.23%

6M

-11.26%

1Y

-11.96%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PRCT vs. AI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRCT
The Risk-Adjusted Performance Rank of PRCT is 4242
Overall Rank
The Sharpe Ratio Rank of PRCT is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of PRCT is 4545
Sortino Ratio Rank
The Omega Ratio Rank of PRCT is 4343
Omega Ratio Rank
The Calmar Ratio Rank of PRCT is 4040
Calmar Ratio Rank
The Martin Ratio Rank of PRCT is 4444
Martin Ratio Rank

AI
The Risk-Adjusted Performance Rank of AI is 4545
Overall Rank
The Sharpe Ratio Rank of AI is 4141
Sharpe Ratio Rank
The Sortino Ratio Rank of AI is 4646
Sortino Ratio Rank
The Omega Ratio Rank of AI is 4444
Omega Ratio Rank
The Calmar Ratio Rank of AI is 4646
Calmar Ratio Rank
The Martin Ratio Rank of AI is 4646
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PRCT vs. AI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and C3.ai, Inc. (AI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current PRCT Sharpe Ratio is -0.25, which is lower than the AI Sharpe Ratio of -0.19. The chart below compares the historical Sharpe Ratios of PRCT and AI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

PRCT vs. AI - Dividend Comparison

Neither PRCT nor AI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PRCT vs. AI - Drawdown Comparison

The maximum PRCT drawdown since its inception was -63.51%, smaller than the maximum AI drawdown of -94.22%. Use the drawdown chart below to compare losses from any high point for PRCT and AI. For additional features, visit the drawdowns tool.


Loading data...

Volatility

PRCT vs. AI - Volatility Comparison

PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 15.24% compared to C3.ai, Inc. (AI) at 12.57%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than AI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

PRCT vs. AI - Financials Comparison

This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and C3.ai, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M20212022202320242025
69.16M
98.78M
(PRCT) Total Revenue
(AI) Total Revenue
Values in USD except per share items

PRCT vs. AI - Profitability Comparison

The chart below illustrates the profitability comparison between PROCEPT BioRobotics Corporation and C3.ai, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-50.0%0.0%50.0%20212022202320242025
63.9%
59.1%
(PRCT) Gross Margin
(AI) Gross Margin
PRCT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, PROCEPT BioRobotics Corporation reported a gross profit of 44.16M and revenue of 69.16M. Therefore, the gross margin over that period was 63.9%.

AI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, C3.ai, Inc. reported a gross profit of 58.35M and revenue of 98.78M. Therefore, the gross margin over that period was 59.1%.

PRCT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, PROCEPT BioRobotics Corporation reported an operating income of -27.44M and revenue of 69.16M, resulting in an operating margin of -39.7%.

AI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, C3.ai, Inc. reported an operating income of -87.59M and revenue of 98.78M, resulting in an operating margin of -88.7%.

PRCT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, PROCEPT BioRobotics Corporation reported a net income of -24.74M and revenue of 69.16M, resulting in a net margin of -35.8%.

AI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, C3.ai, Inc. reported a net income of -80.20M and revenue of 98.78M, resulting in a net margin of -81.2%.